MedTrace Logo

N-acetylcysteine Treatment of Alcohol Use Disorder In Veterans With TBI

NCT02791945 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-05-11

Study results available
· View outcomes & findings →

Summary

The goal of the project is to improve the care of Veterans with mild traumatic brain injury (mTBI) and unhealthy alcohol use.

Conditions

  • Traumatic Brain Injury (TBI)
  • Hazardous and Harmful Alcohol Use

Interventions

BEHAVIORAL

Medical Management Counseling

Brief alcohol counseling

DRUG

N-acetylcysteine

Experimental supplement

DRUG

Placebo

Placebo comparator

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • Northern California Institute of Research and Education

    collaborator OTHER

  • San Francisco Veterans Affairs Medical Center

    collaborator FED

  • Institute for Translational Neuroscience

    collaborator UNKNOWN

  • University of California, San Francisco

    lead OTHER

Principal Investigators

  • Steven L. Batki, MD · Unviersity of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2018-05-31
Completion
2018-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02791945 on ClinicalTrials.gov